Thomas Urban Marron, Zev A. Wainberg, Alexander I. Spira, Michael S. Gordon, Christopher T. Chen, Jennifer Margaret Segar, Aaron J. Scott, Ralph V. Boccia, Daniel H. Johnson, Jordan Berlin, Won Jin Ho, Juergen Schanzer, Deepanwita Sengupta, Ningwu Huang, Jeffrey S. Glenn, Ildiko Csiki, Klaus Klumpp, Jamal Ghazi Misleh. "Completed phase 1a dose escalation study of the first oral ENPP1 inhibitor RBS2418 immunotherapy in subjects with metastatic solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.2577